Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the RBC Capital Markets 2024 Global Healthcare Conference. The fireside chat will take place on Wednesday, May 15 beginning at 1:35 p.m. Eastern Time. A link to the event can be accessed